Cases 11 - 20 of 64
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Lupin Ltd. et al
as 1:2021cv00530
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv00425
Defendant:
Teva Pharmaceuticals USA, Inc., Cadila Healthcare Ltd. doing business as Zydus Cadila, Actavis LLC and others
Plaintiff:
Astellas Pharma Global Development, Inc., Astellas Pharma Inc. and Astellas Ireland Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
UCB, Inc. et al v. Annora Pharma Private Limited et al
as 1:2020cv00987
Defendant:
Aurobindo Pharma USA Inc., Lupin Ltd., Apotex Corp. and others
Plaintiff:
UCB Biopharma SRL and UCB, Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim International GmbH et al v. Lupin Ltd. et al
as 1:2019cv01866
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. v. Lupin Ltd. et al
as 1:2019cv01497
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin Ltd.
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc. and Boehringer Ingelheim International GmbH
Cause Of Action: 35 U.S.C. § 271
In re: Auryxia (Ferric Citrate) Patent Litigation
as 1:2019md02896
Not Classified By Court:
Chemo Research S.L., Insud Pharma S.L., Teva Pharmaceuticals USA, Inc. and others
Counter Defendant:
Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc. and Chen Hsing Hsu
Counter Claimant:
Lupin Atlantis Holdings SA and Lupin Ltd.
In Re:
In re: Auryxia (Ferric Citrate) Patent Litigation
Cause Of Action: 35 U.S.C. § 271
Teva Pharmaceuticals International GmbH et al v. Lupin, Ltd. et al
as 1:2019cv01251
Defendant:
Lupin Pharmaceuticals, Inc. and Lupin, Ltd.
Plaintiff:
Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. and Cephalon, Inc.
Cause Of Action: 35 U.S.C. § 271
Ferring Pharmaceuticals Inc. et al v. Lupin Inc. et al
as 1:2019cv00913
Defendant:
Lupin Ltd., Lupin Inc., Lupin Pharmaceuticals, Inc. and others
Plaintiff:
Ferring B.V., Ferring Pharmaceuticals Inc. and Ferring International Center S.A.
Cause Of Action: 35 U.S.C. § 183
Keryx Biopharmaceuticals, Inc. et al v. Lupin Ltd.
as 1:2019cv00884
Plaintiff:
Keryx Biopharmaceuticals, Inc., Chen Hsing Hsu and Panion & BF Biotech, Inc.
Defendant:
Lupin Ltd.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
